BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20487670)

  • 1. Are excipients really inert ingredients? A review of adverse reactions to excipients in oral dermatologic medications in Canada.
    Noiles K; Vender R
    J Cutan Med Surg; 2010; 14(3):105-14. PubMed ID: 20487670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sweeteners, dyes, and other excipients in vitamin and mineral preparations.
    Kumar A; Aitas AT; Hunter AG; Beaman DC
    Clin Pediatr (Phila); 1996 Sep; 35(9):443-50. PubMed ID: 8877241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1997 Feb; 99(2):268-78. PubMed ID: 9024461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mystery ingredients: sweeteners, flavorings, dyes, and preservatives in analgesic/antipyretic, antihistamine/decongestant, cough and cold, antidiarrheal, and liquid theophylline preparations.
    Kumar A; Rawlings RD; Beaman DC
    Pediatrics; 1993 May; 91(5):927-33. PubMed ID: 7682684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excipients and additives: hidden hazards in drug products and in product substitution.
    Napke E; Stevens DG
    Can Med Assoc J; 1984 Dec; 131(12):1449-52. PubMed ID: 6498699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in the formulation of drugs for oral use in children: role of excipients.
    Pawar S; Kumar A
    Paediatr Drugs; 2002; 4(6):371-9. PubMed ID: 12038873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfite-containing Canadian pharmaceutical products available in 1991.
    Miyata M; Schuster B; Schellenberg R
    CMAJ; 1992 Nov; 147(9):1333-8. PubMed ID: 1483237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse reactions to sulfites.
    Yang WH; Purchase EC
    CMAJ; 1985 Nov; 133(9):865-7, 880. PubMed ID: 4052897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excipients in Anesthesia Medications.
    Burbridge MA; Jaffe RA
    Anesth Analg; 2019 May; 128(5):891-900. PubMed ID: 29505449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls of 'inert' ingredients.
    Millar JS
    Br J Gen Pract; 2001 Jul; 51(468):570. PubMed ID: 11462319
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
    Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
    Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).
    Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
    Med Toxicol Adverse Drug Exp; 1988; 3(3):209-40. PubMed ID: 3041246
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lactose intolerance: lactose intolerant patients can they use medications that contain lactose?].
    Leuckx S
    J Pharm Belg; 2011 Sep; (3):81. PubMed ID: 21995100
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication dyes as a source of drug allergy.
    Swerlick RA; Campbell CF
    J Drugs Dermatol; 2013 Jan; 12(1):99-102. PubMed ID: 23377335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the 'hidden' lactose in drugs used for the treatment of gastrointestinal conditions.
    Eadala P; Waud JP; Matthews SB; Green JT; Campbell AK
    Aliment Pharmacol Ther; 2009 Mar; 29(6):677-87. PubMed ID: 19035974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic excipients: Importance of clinical awareness of inactive ingredients.
    Ionova Y; Wilson L
    PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.
    Liu M; Huang YY; Hsu S; Kass JS
    CNS Drugs; 2016 Dec; 30(12):1149-1168. PubMed ID: 27832476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical excipients and the information on drug labels.
    Balbani AP; Stelzer LB; Montovani JC
    Braz J Otorhinolaryngol; 2006; 72(3):400-6. PubMed ID: 17119779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sweeteners, flavorings, and dyes in antibiotic preparations.
    Kumar A; Weatherly MR; Beaman DC
    Pediatrics; 1991 Mar; 87(3):352-60. PubMed ID: 2000275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic with lactose intolerance. Is there a drug without lactose?].
    Stichtenoth DO
    MMW Fortschr Med; 2010 Nov; 152(46):24; author reply 24. PubMed ID: 21229719
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.